1. Home
  2. IAC vs SYRE Comparison

IAC vs SYRE Comparison

Compare IAC & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IAC Inc.

IAC

IAC Inc.

HOLD

Current Price

$39.50

Market Cap

2.7B

Sector

Technology

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$32.25

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IAC
SYRE
Founded
N/A
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.6B
IPO Year
1992
2016

Fundamental Metrics

Financial Performance
Metric
IAC
SYRE
Price
$39.50
$32.25
Analyst Decision
Buy
Strong Buy
Analyst Count
12
6
Target Price
$45.91
$56.50
AVG Volume (30 Days)
759.3K
598.5K
Earning Date
02-03-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,653,760,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
23.49
N/A
52 Week Low
$29.56
$10.91
52 Week High
$50.49
$35.31

Technical Indicators

Market Signals
Indicator
IAC
SYRE
Relative Strength Index (RSI) 54.03 50.75
Support Level $38.39 $31.62
Resistance Level $40.52 $35.07
Average True Range (ATR) 1.02 1.88
MACD -0.16 0.01
Stochastic Oscillator 53.66 59.45

Price Performance

Historical Comparison
IAC
SYRE

About IAC IAC Inc.

IAC Inc is comprised of businesses including Angi Inc, Dotdash Meredith and Care.com, among many others ranging from early stage to established businesses. Its Dotdash Meredith segment consists of its Digital and Print businesses. Angi segment offers repairing and remodeling homes to cleaning and landscaping services. Care.com segment is a online destination for families to connect with caregivers for their children, aging parents, pets and homes and for caregivers to connect with families seeking care services. Search segment consists of a collection of websites providing general search services and information, and a Desktop business, which includes business-to-business partnership operations.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: